← All trials
NCT00300937
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2004
- Primary completion
- —
- Completion date
- Sep 1, 2006
- First posted
- —
- Last posted
- —
- Enrollment
- 235
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Central University of EcuadorLead sponsor
- Jarrow Formulas IncCollaborator
- Ecuadorian Foundation for Science and TechnologyCollaborator
- Central University of EcuadorStudy director
- Central University of EcuadorCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.